Probiotic Dosing Guidelines for Lactobacillus acidophilus and Bifidobacterium

Standard Dosing by Clinical Context

For general health maintenance and gastrointestinal support in ambulatory adults, the American College of Gastroenterology recommends using Lactobacillus acidophilus at 10⁹ CFU/day combined with Bifidobacterium species at 10⁹ to 10¹⁰ CFU/day, administered as capsules or sachets 1
Multi-strain formulations containing both organisms show enhanced efficacy compared to single strains, as recommended by the American Gastroenterological Association 1

Higher doses of 2.5 × 10⁹ to 4 × 10¹¹ CFU/day are required for ICU patients, according to the Society of Critical Care Medicine 1, 2, 3
For severe acute pancreatitis, the recommended dose is 2.5 × 10⁹ CFU per sachet, 4 sachets daily (total 10¹⁰ CFU/day) of combined L. acidophilus and Bifidobacterium species, as suggested by the American College of Gastroenterology 4
For craniocerebral trauma, the recommended dose is 1 × 10⁹ CFU three times daily (3 × 10⁹ CFU/day total), according to the Brain Injury Foundation 2, 4

For antibiotic-associated diarrhea prevention, the American College of Gastroenterology recommends continuing probiotics throughout the antibiotic course plus 5-7 days post-completion 1
For acute gastroenteritis, the recommended duration is 5-7 days, as suggested by the American Academy of Pediatrics 1
For IBS and functional bowel disorders, the minimum recommended duration is 4-6 weeks with assessment at 12 weeks, according to the American Gastroenterological Association 1

For ambulatory patients, the American College of Gastroenterology recommends capsules or sachets (standard) 1
For swallowing difficulties, the Society of Critical Care Medicine suggests nasogastric or nasojejunal tube 1, 2, 3
For mechanically ventilated patients, the American Thoracic Society recommends liquid formulations for oral care (8 × 10⁹ CFU daily) 5

The American College of Gastroenterology states that probiotics are absolutely contraindicated in immunocompromised patients due to bacteremia risk 1, 6
The British Society of Gastroenterology explicitly advises against the use of probiotics in patients with Crohn's disease based on very low-quality evidence showing no benefit for induction or maintenance of remission 8